Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation

Documenti analoghi

• Patterns of recurrence after curative resection and adjuvant chemotherapy in gastric and gastroesophageal junction cancer
  di: Chengzhi Wei, et al.
  Pubblicazione: (2026)
• Risk of second primary malignancies after adjuvant chemotherapy for colon cancer
  di: Tomas Buchler, et al.
  Pubblicazione: (2025)
• Prognostic impact of shift to low visceral fat mass after neoadjuvant chemotherapy in patients with esophageal cancer
  di: Sachiyo Onishi, et al.
  Pubblicazione: (2024)
• Impact of intra‐tumoral immunity on predicting response and survival after neoadjuvant cisplatin‐based chemotherapy in patients with muscle invasive bladder cancer
  di: Alberto Mendoza‐Valderrey, et al.
  Pubblicazione: (2024)
• Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer
  di: Osamu Maeda, et al.
  Pubblicazione: (2024)